Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
Clinical trial NCT03964922 · UNKNOWN
Trial details
- NCT number
- NCT03964922
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2022-06-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.